chr14-91234261-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001177676.2(GPR68):c.790G>A(p.Val264Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,557,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001177676.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR68 | NM_001177676.2 | c.790G>A | p.Val264Ile | missense_variant | 2/2 | ENST00000650645.1 | NP_001171147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR68 | ENST00000650645.1 | c.790G>A | p.Val264Ile | missense_variant | 2/2 | NM_001177676.2 | ENSP00000498702 | P1 | ||
GPR68 | ENST00000531499.2 | c.790G>A | p.Val264Ile | missense_variant | 2/2 | 1 | ENSP00000434045 | P1 | ||
GPR68 | ENST00000535815.5 | c.790G>A | p.Val264Ile | missense_variant | 2/2 | 1 | ENSP00000440797 | P1 | ||
GPR68 | ENST00000529102.1 | c.790G>A | p.Val264Ile | missense_variant | 2/2 | 1 | ENSP00000432740 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152268Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000126 AC: 21AN: 166720Hom.: 0 AF XY: 0.000133 AC XY: 12AN XY: 89942
GnomAD4 exome AF: 0.0000520 AC: 73AN: 1404962Hom.: 0 Cov.: 33 AF XY: 0.0000762 AC XY: 53AN XY: 695252
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74388
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at